Cargando…
A method to study the effect of bronchodilators on smoke retention in COPD patients: study protocol for a randomized controlled trial
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a common disease, associated with cardiovascular disease. Many patients use (long-acting) bronchodilators, whilst they continue smoking alongside. We hypothesised an interaction between bronchodilators and smoking that enhances smoke exposu...
Autores principales: | van Dijk, WD, Scheepers, PTJ, Cremers, R, Lenders, JWM, Klerx, W, van Weel, C, Schermer, TRJ, Heijdra, Y |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048554/ https://www.ncbi.nlm.nih.gov/pubmed/21310040 http://dx.doi.org/10.1186/1745-6215-12-37 |
Ejemplares similares
-
Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD
por: Kardos, Peter, et al.
Publicado: (2016) -
Bronchodilators for hyperinflation in COPD associated with biomass smoke: clinical trial
por: Ramírez-Venegas, Alejandra, et al.
Publicado: (2019) -
Which bronchodilator in COPD?
por: Russell, Richard, et al.
Publicado: (2007) -
COPD: maximization of bronchodilation
por: Nardini, Stefano, et al.
Publicado: (2014) -
Bronchodilators use in patients with COPD
por: Dong, Yaa-Hui, et al.
Publicado: (2015)